Authors: Lehmann, MH Schreiber, S Vogelsang, H Sigusch, HH

Citation: Mh. Lehmann et al., Constitutive expression of MCP-1 and RANTES in the human histiocytic lymphoma cell line U-937, IMMUNOL LET, 76(2), 2001, pp. 111-113

Authors: Sigusch, HH Lehmann, MH Schnittler, U Reinhardt, D Figulla, HR

Citation: Hh. Sigusch et al., Tumour necrosis factor-alpha expression in idiopathic dilated cardiomyopathy: Correlation to myocardial inflammatory activity, CYTOKINE, 12(8), 2000, pp. 1261-1266

Authors: Sigusch, HH Surber, R Lehmann, MH Surber, S Weber, J Henke, A Reinhardt, D Hoffmann, A Figulla, HR

Citation: Hh. Sigusch et al., Lack of association between 27-bp repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene and the risk of coronary artery disease, SC J CL INV, 60(3), 2000, pp. 229-235

Authors: Reinhardt, D Sigusch, HH Vogt, SF Zeiss, C Farker, K Hoffmann, A Muller, S

Citation: D. Reinhardt et al., A common variant of the angiotensinogen gene and the risk of coronary artery disease in a German population, PHARMAZIE, 55(1), 2000, pp. 69-71

Authors: Surber, R Sigusch, HH Lehmann, MH Reinhardt, D Hoffmann, A Figulla, HR

Citation: R. Surber et al., Angiotensin II type 1 receptor gene polymorphism is associated with the severity but not prevalence of coronary artery disease, CLIN GENET, 58(3), 2000, pp. 237-238

Authors: Grohmann, G Sigusch, HH Reinhardt, D Pohlmann, G Hoffman, A Figulla, HR

Citation: G. Grohmann et al., Genetic risk factors for phlebothrombosis: New aspects under special consideration of the inherited resistance to activated protein C (coagulation factor V Leiden)., PERFUSION, 12(7), 1999, pp. 271